ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Tolerance"

  • 2019 American Transplant Congress

    Novel Flow-Based Assay to Identify Allo-Specific T Cell Exhaustion

    N. Tanimine1, C. Rickert1, K. Lee1, K. Deng1, N. Feeney1, C. Leguern1, B. Burrell2, J. Markmann1

    1Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Immune Tolerance Network, Bethesda, MD

    *Purpose: A recent, multi-center immunosuppression withdrawal trial in liver transplant recipients unexpectedly revealed time post-transplant as an important predictor for operational tolerance. We hypothesize that…
  • 2019 American Transplant Congress

    Full and Sustained Donor Hematopoietic Chimerism after an Isolated Kidney Transplantation

    J. Zuber1, O. Boyer1, B. Neven1, E. Six2, R. Berthaud1, M. Ould Rabah1, S. Sobrino2, C. Lagresle2, I. André-Schmutz2, M. Cavazzana1, S. Blanche1, R. Salomon1

    1Paris Descartes University, Paris, France, 2Inserm UMRS 1163, Paris, France

    *Purpose: Full donor chimerism was reported three times in the absence of myelosuppressive regimen, only after liver or multivisceral transplantation, but never after kidney transplantation.…
  • 2019 American Transplant Congress

    Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells

    D. V. Tran, A. N. Suah, S. Khiew, J. S. Young, Q. Wang, D. Yin, M. Alegre, A. S. Chong

    Departments of Surgery and Medicine, University of Chicago, Chicago, IL

    *Purpose: Clinical data suggest allogeneic pregnancy is a sensitizing event; however, data from mouse models suggests it induces fetal-specific regulatory T cell (Treg) expansion and…
  • 2019 American Transplant Congress

    Preliminary Mechanistic Studies of Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplant Recipients

    A. Thomson, C. Macedo, A. Zahorchak, H. Dai, A. Humar, F. G. Lakkis, M. Styn, D. Metes

    Starzl Transplantation Institute, Pittsburgh, PA

    *Purpose: This is a first-in-human phase I/II safety and preliminary efficacy trial of donor-derived regulatory dendritic cells (DCreg) in living donor liver transplantation (LTx) in…
  • 2019 American Transplant Congress

    A Kidney Transplant Recipient with Severe Acute GvHD Promptly Rescued by Donor HLA-Targeted Serotherapy

    J. Zuber1, O. Boyer1, B. Neven1, R. Berthaud1, M. Ould Rabah1, I. Jollet2, V. Renac2, F. Pirenne2, S. Gross2, R. Djoudi2, P. Tiberghien2, J. Taupin3, S. Blanche1, R. Salomon1

    1Paris Descartes University, Paris, France, 2Etablissement Français du Sang, Paris, France, 3Department of Immunology and Histocompatibility, St Louis Hospital, Paris, France

    *Purpose: Acute Graft-versus-Host Disease (GvHD) is a rare but frequently lethal complication after solid organ transplantation (SOT). In intestinal transplant recipients, anti-HLA Donor-Specific Antibody (DSA)…
  • 2019 American Transplant Congress

    Long-Term Kidney Graft Evolution in Simultaneous Liver-Kidney Transplants with Immunological Risk

    G. J. Piñeiro1, E. Montagud1, J. Ugalde1, R. Gelpi1, V. Torregrosa1, J. Rovira2, J. Colmenero3, F. Diekmann1, N. Esforzado1

    1Nephrology and Kidney Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain, 2Nephrology and Kidney Transplantation, Laboratori Experimental de Nefrologia i Trasplantament, IDIBAPS, Barcelona, Spain, 3Liver Transplant Unit, Hospital Clínic of Barcelona, Barcelona, Spain

    *Purpose: There is disagreement about the real impact of anti-HLA sensitization on patient and kidney graft survival in simultaneous liver-kidney transplant (SLKT).*Methods: We reviewed the…
  • 2019 American Transplant Congress

    Responder B Cell Depletion Increased Allo-Reactive Regulatory T Cells Generated in Allo-Anergization

    N. Tanimine1, L. Contreras-Ruiz2, K. Deng1, N. Feeney1, C. Rickert1, K. Lee1, E. Guinan3, J. Markmann1

    1Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 3Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA

    *Purpose: Regulatory T cells (Tregs) are promising tool for induction and maintenance of transplantation tolerance. We have done a feasibility trial in kidney transplant recipients…
  • 2019 American Transplant Congress

    Chimeric Allografts Induced by Stem Cell Mobilizing Agents in a Mouse Model of Kidney Transplantation: Role of CD133 Stem Cells

    J. Zhou, l. Qi, A. Ahmadi, R. Wesson, A. Cameron, J. Burdick, Z. Sun

    Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: It has been reported that a stem cell mobilizing therapy using a combination of AMD3100 and low dose FK506 (AF) enabled immunosuppressive-free long-term kidney…
  • 2019 American Transplant Congress

    An Open-Label Proof-of-Principle Phase 2A Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

    A. Chruscinski1, H. Atkins2, A. Clement2, D. Grant1, C. Bredsen2, E. Renner1, J. Zhang1, M. Epstein1, L. Lilly1, N. Selzner1, O. Adeyi1, R. Smith1, S. Moshkelgosha1, A. Humar1, S. Juvet1, G. Levy1

    1Multi-Organ Transplantation, University Health Network, Toronto, ON, Canada, 2Ottawa Hospital Research Institute, Ottawa, ON, Canada

    *Purpose: Long-term survival of recipients of solid organ transplants is hampered by chronic rejection, disease recurrence and immunosuppression-induced toxicity. Self-tolerance is re-established after autologous hematopoietic…
  • 2019 American Transplant Congress

    Regulating T Cell Responses by Forced Transgenic Expression of Decay-Accelerating Factor

    D. Heja1, Z. He1, S. A. Lira1, F. Lin2, D. Homann1, P. S. Heeger1

    1Icahn School of Medicine at Mount Sinai, New York, NY, 2Cleveland Clinic, Cleveland, OH

    *Purpose: Decay-accelerating factor (DAF, CD55) is a cell surface expressed, glycophosphatidylinositol-(GPI)-anchored, complement regulator. Previous studies showed that during cognate T cell/antigen presenting cell (APC) interactions…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 57
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences